Considering that PD-L1 in cancer cells mediates trastuzumab resistance by promoting immune evasion and enhancing cancer cell growth, we focused on the effect of YAP inhibition on PD-L1 expression in HR cells [32, 33]. This evidence concerns the gene YAP1 and cancer.